TRAVERE THERAPEUTICS, INC.: operating_income
| Value | {"amount": -319813000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4ac06ca1-723d-4ddf-9a4d-276674914c57
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-24-000005Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/operating-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4ac06ca1-723d-4ddf-9a4d-276674914c57
History
- supersedes {"amount": -266566000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001438533-23-000008)